|
US5585254A
(en)
*
|
1987-08-21 |
1996-12-17 |
University Of Colorado Foundation, Inc. |
Autonomous parvovirus gene delivery vehicles and expression vectors
|
|
US7238673B2
(en)
|
1989-03-31 |
2007-07-03 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
US5698531A
(en)
|
1989-03-31 |
1997-12-16 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
US5643567A
(en)
*
|
1990-12-04 |
1997-07-01 |
Board Of Regents, The University Of Texas System |
Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
|
|
US6627615B1
(en)
|
1991-12-17 |
2003-09-30 |
The Regents Of The University Of California |
Methods and compositions for in vivo gene therapy
|
|
US6001644A
(en)
*
|
1991-12-17 |
1999-12-14 |
The Regents Of The University Of California |
Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
|
|
US5858784A
(en)
|
1991-12-17 |
1999-01-12 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol- and liposome-based delivery
|
|
US6806084B1
(en)
|
1992-06-04 |
2004-10-19 |
The Regents Of The University Of California |
Methods for compositions for in vivo gene delivery
|
|
EP0646178A1
(de)
*
|
1992-06-04 |
1995-04-05 |
The Regents Of The University Of California |
Expression kassette mit im säugetier wirt funktionnellen regulator sequenzen
|
|
WO1994005782A1
(en)
*
|
1992-09-10 |
1994-03-17 |
Trustees Of Tufts College |
In vivo production of transgenic organ by introducing the transgene via lumen
|
|
US5821234A
(en)
*
|
1992-09-10 |
1998-10-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibition of proliferation of vascular smooth muscle cell
|
|
US6015886A
(en)
*
|
1993-05-24 |
2000-01-18 |
Chemgenes Corporation |
Oligonucleotide phosphate esters
|
|
US5645829A
(en)
*
|
1993-06-18 |
1997-07-08 |
Beth Israel Hospital Association |
Mesothelial cell gene therapy
|
|
US6197553B1
(en)
|
1994-07-15 |
2001-03-06 |
Merck & Co., Inc. |
Method for large scale plasmid purification
|
|
ES2227557T3
(es)
*
|
1994-07-15 |
2005-04-01 |
MERCK & CO., INC. |
Procedimiento para la purificacion a gran escala de plasmidos.
|
|
US20020103147A1
(en)
|
1997-09-05 |
2002-08-01 |
Hammond H. Kirk |
Gene therapy for congestive heart failure
|
|
US6752987B1
(en)
|
1995-02-28 |
2004-06-22 |
The Regents Of The University Of California |
Adenovirus encoding human adenylylcyclase (AC) VI
|
|
US6100242A
(en)
|
1995-02-28 |
2000-08-08 |
The Regents Of The University Of California |
Gene therapies for enhancing cardiac function
|
|
US5885971A
(en)
*
|
1995-03-24 |
1999-03-23 |
The Regents Of The University Of California |
Gene therapy by secretory gland expression
|
|
US6531455B1
(en)
|
1995-03-24 |
2003-03-11 |
The Regents Of The University Of California |
Delivery of polynucleotides by secretory gland expression
|
|
AR003122A1
(es)
*
|
1995-05-19 |
1998-07-08 |
Merck & Co Inc |
Un proceso para aislacion y purificacion de plasmidos en fermentadores de gran escala y el adn aislado y purificado obtenido mediante dicho proceso.
|
|
ES2240999T3
(es)
|
1995-08-29 |
2005-10-16 |
Anges Mg, Inc. |
Medicamento que contiene un gen del hgf.
|
|
IL115199A
(en)
*
|
1995-09-07 |
2005-05-17 |
Opperbas Holding Bv |
Composition comprising a polynucleic acid molecule in a liposome and method using said composition
|
|
JP2765814B2
(ja)
*
|
1995-11-24 |
1998-06-18 |
コナミ株式会社 |
ビデオゲーム装置及びビデオゲームのプレイキャラクタ成長制御方法
|
|
US5783566A
(en)
*
|
1996-05-10 |
1998-07-21 |
California Institute Of Technology |
Method for increasing or decreasing transfection efficiency
|
|
US6225290B1
(en)
|
1996-09-19 |
2001-05-01 |
The Regents Of The University Of California |
Systemic gene therapy by intestinal cell transformation
|
|
US7112338B2
(en)
|
1997-03-12 |
2006-09-26 |
The Regents Of The University Of California |
Cationic liposome delivery of taxanes to angiogenic blood vessels
|
|
US5837283A
(en)
|
1997-03-12 |
1998-11-17 |
The Regents Of The University Of California |
Cationic lipid compositions targeting angiogenic endothelial cells
|
|
ATE298371T1
(de)
|
1997-09-24 |
2005-07-15 |
Univ California |
Nicht-primaten lentivirale vektoren und verpackungssysteme
|
|
JP2002500190A
(ja)
|
1998-01-08 |
2002-01-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
海洋海綿から誘導されるキネシンモーターモジュレーター
|
|
US6410328B1
(en)
|
1998-02-03 |
2002-06-25 |
Protiva Biotherapeutics Inc. |
Sensitizing cells to compounds using lipid-mediated gene and compound delivery
|
|
JP2002502831A
(ja)
|
1998-02-03 |
2002-01-29 |
イネックス ファーマシューティカルズ コーポレイション |
癌の治療に用いる血清に対して安定なプラスミド脂質粒子の全身供与
|
|
ES2326146T3
(es)
|
1998-06-17 |
2009-10-01 |
Idm Pharma, Inc. |
Peptidos de union a hla y sus usos.
|
|
JP2002538167A
(ja)
|
1999-03-03 |
2002-11-12 |
バイオジェン インコーポレイテッド |
脂質の代謝および貯蔵を調節する方法
|
|
US7396905B1
(en)
|
1999-05-21 |
2008-07-08 |
Mckeon Frank |
Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto
|
|
EP1194449B1
(de)
|
1999-06-28 |
2010-09-22 |
Oklahoma Medical Research Foundation |
Inhibitoren des memapsin 2 und ihre verwendung
|
|
EP1136083B1
(de)
|
1999-10-08 |
2008-05-14 |
AnGes MG, Inc. |
Hgf zur gentherapie der karidomyopathie
|
|
EP2177534A3
(de)
|
1999-11-18 |
2010-07-14 |
Pharmexa Inc. |
Heteroklitische Analoga von Klasse-i Epitopen
|
|
US6926898B2
(en)
|
2000-04-12 |
2005-08-09 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
EP2022797A3
(de)
|
2000-08-28 |
2011-11-09 |
Agensys, Inc. |
Nukleinsäure und entsprechendes Protein mit der Bezeichnung 85P1B3 für die Behandlung und den Nachweis von Krebs
|
|
US7767802B2
(en)
|
2001-01-09 |
2010-08-03 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of anti-apoptotic genes
|
|
US6924358B2
(en)
|
2001-03-05 |
2005-08-02 |
Agensys, Inc. |
121P1F1: a tissue specific protein highly expressed in various cancers
|
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
|
WO2002077012A2
(en)
|
2001-03-23 |
2002-10-03 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Human papilloma virus immunoreative peptides
|
|
US7176300B2
(en)
|
2001-03-30 |
2007-02-13 |
Avigenics, Inc. |
Avian lysozyme promoter
|
|
US7541512B2
(en)
|
2001-03-30 |
2009-06-02 |
Synageva Biopharma Corp. |
Avians containing a lysozyme promoter transgene
|
|
WO2002079447A2
(en)
|
2001-03-30 |
2002-10-10 |
Avigenics, Inc. |
Avian lysozyme promoter
|
|
EP1573024A4
(de)
|
2001-04-10 |
2007-08-29 |
Agensys Inc |
Nukleinsäuren und diesen entprechende, für die behandlung und den nachweis verschiedener krebserkrankungen geeignete proteine
|
|
US20030191073A1
(en)
|
2001-11-07 |
2003-10-09 |
Challita-Eid Pia M. |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
|
|
BR0211111A
(pt)
|
2001-07-12 |
2004-06-22 |
Univ Massachusetts |
Molécula de ácido nucleico isolada, vetor, célula hospedeira, transgene, precursor de rna engenheirado, animal transgênico não humano, e, método de induzir a interferência de ácido ribonucleico de um gene alvo em uma célula
|
|
EP1900815B1
(de)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In-vivo-Herstellung kleiner interferierender und Genverstummung vermittelnder RNAs
|
|
WO2003022995A2
(en)
|
2001-09-06 |
2003-03-20 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
|
|
US7745418B2
(en)
|
2001-10-12 |
2010-06-29 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting viral replication
|
|
CA2841097A1
(en)
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin and g-csf fusion proteins
|
|
US7282222B2
(en)
|
2002-03-15 |
2007-10-16 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Methods and compositions for directing cells to target organs
|
|
US20040081653A1
(en)
|
2002-08-16 |
2004-04-29 |
Raitano Arthur B. |
Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
|
|
JP2006512300A
(ja)
|
2002-10-03 |
2006-04-13 |
エピミューン インコーポレイテッド |
Hla結合ペプチド及びその使用
|
|
AU2002352976B2
(en)
|
2002-11-27 |
2007-11-08 |
Agensys, Inc. |
Nucleic acid corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
|
|
EP1903056A3
(de)
|
2002-12-10 |
2008-05-07 |
Idm Pharma, Inc. |
HLA-A1, -A2, -A3, -A24, -B7 and -B44 bindende Peptide die Tumorassoziiert-Antigen Epitopen enthalten, und Zusammensetzungen davon
|
|
PT1587923E
(pt)
|
2003-01-22 |
2011-12-07 |
Univ Duke |
Construções melhoradas para a expressão de polipéptidos lisossomais
|
|
CA2860151A1
(en)
|
2003-02-10 |
2004-08-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
|
|
AU2004263823B2
(en)
|
2003-05-30 |
2008-09-18 |
Agensys, Inc. |
Prostate stem cell antigen (PSCA) variants and subsequences thereof
|
|
CA2528012C
(en)
|
2003-06-02 |
2015-11-24 |
University Of Massachusetts |
Methods and compositions for controlling efficacy of rna silencing
|
|
CA2527958C
(en)
|
2003-06-02 |
2014-04-08 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of rnai
|
|
ES2905724T3
(es)
|
2003-06-13 |
2022-04-11 |
Alnylam Europe Ag |
Acido ribonucleico bicatenario con elevada eficacia en un organismo
|
|
DK1677735T3
(da)
|
2003-10-17 |
2014-10-27 |
Joslin Diabetes Center Inc |
Fremgangsmåder og sammensætninger til modulering af adipocytfunktion
|
|
US7608699B2
(en)
|
2003-12-29 |
2009-10-27 |
Rockefeller University |
Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof
|
|
EP1723227A4
(de)
|
2004-02-10 |
2007-09-19 |
Dartmouth College |
Nicotinamidribosid-kinase-zusammensetzungen und verfahren zu deren verwendung
|
|
EP1765847A4
(de)
|
2004-05-27 |
2010-10-20 |
Alnylam Pharmaceuticals Inc |
Nukleaseresistente doppelsträngige ribonukleinsäure
|
|
RU2381234C2
(ru)
|
2004-05-28 |
2010-02-10 |
Эдженсис, Инк. |
Антитела и родственные молекулы, связывающиеся с белками psca
|
|
EP1789070B1
(de)
|
2004-08-03 |
2012-10-24 |
Biogen Idec MA Inc. |
Taj in der neuronalen funktion
|
|
BRPI0607306A2
(pt)
|
2005-01-25 |
2009-08-25 |
Prolexys Pharmaceuticals Inc |
derivados de quinoxalina como agentes anti-tumor
|
|
EP3300739A3
(de)
|
2005-03-31 |
2018-07-18 |
Agensys, Inc. |
An 161p2f10b-proteine bindende antikörper und zugehörige moleküle
|
|
UA95446C2
(ru)
|
2005-05-04 |
2011-08-10 |
Іллюміджен Байосайєнсіз, Інк. |
Мутаци в генах oas1
|
|
US20100119489A1
(en)
|
2005-06-07 |
2010-05-13 |
Markus Stoffel |
Stimulation of Pancreatic Beta Cell Proliferation
|
|
EP1907533A4
(de)
|
2005-06-30 |
2008-09-03 |
Whitehead Biomedical Inst |
Vorläuferzellen und verwendungen dafür
|
|
US7943134B2
(en)
|
2005-08-31 |
2011-05-17 |
Academia Sinica |
Compositions and methods for identifying response targets and treating flavivirus infection responses
|
|
EP2325315B1
(de)
|
2005-10-28 |
2014-05-07 |
Alnylam Pharmaceuticals, Inc. |
Zusammensetzungen und Verfahren zur Hemmung der Expression des Huntingtin-Gens
|
|
CA2626690A1
(en)
|
2005-11-09 |
2007-05-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of factor v leiden mutant gene
|
|
US20120208824A1
(en)
|
2006-01-20 |
2012-08-16 |
Cell Signaling Technology, Inc. |
ROS Kinase in Lung Cancer
|
|
JP5554925B2
(ja)
|
2006-01-20 |
2014-07-23 |
セル・シグナリング・テクノロジー・インコーポレイテツド |
ヒト非小細胞肺癌における転座及び変異体rosキナーゼ
|
|
PL2450437T3
(pl)
|
2006-04-14 |
2017-12-29 |
Cell Signaling Technology Inc |
Defekty genu i zmutowana kinaza ALK w ludzkich guzach litych
|
|
JP2010500011A
(ja)
|
2006-08-08 |
2010-01-07 |
ガンサー ハートマン |
5’リン酸オリゴヌクレオチドの構造および使用
|
|
EP2338499A1
(de)
|
2006-10-10 |
2011-06-29 |
Gunther Hartmann |
5' Triphosphat -oligonukleotid induziert eine antivirale Reaktion
|
|
US8664364B2
(en)
|
2007-01-24 |
2014-03-04 |
Carnegie Mellon University |
Optical biosensors
|
|
WO2008116347A1
(en)
|
2007-03-26 |
2008-10-02 |
General Regeneratives Limited |
Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
|
|
EP3072963B1
(de)
|
2007-10-18 |
2020-04-01 |
Cell Signaling Technology, Inc. |
Translokation und mutations-ros-kinase bei menschlichem nicht-kleinzelligem bronchialkarzinom
|
|
EP3085707B1
(de)
|
2007-11-01 |
2019-02-27 |
Mayo Foundation for Medical Education and Research |
Hla-dr-bindende peptide und deren anwendungen
|
|
CA2703263C
(en)
|
2007-11-01 |
2014-03-18 |
Perseid Therapeutics Llc |
Immunosuppressive polypeptides and nucleic acids
|
|
US9738680B2
(en)
|
2008-05-21 |
2017-08-22 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
5′ triphosphate oligonucleotide with blunt end and uses thereof
|
|
WO2010039548A2
(en)
|
2008-09-23 |
2010-04-08 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
|
CN102307996A
(zh)
|
2009-02-03 |
2012-01-04 |
弗·哈夫曼-拉罗切有限公司 |
用于抑制ptp1b基因表达的组合物和方法
|
|
SI2881402T1
(sl)
|
2009-02-12 |
2017-12-29 |
Cell Signaling Technology, Inc. |
Ekspresija mutantnega ros pri humanem raku jeter
|
|
JP2012518072A
(ja)
|
2009-02-18 |
2012-08-09 |
カーネギー メロン ユニバーシティ |
明検出のためのクエンチャー付加デンドリマー色素
|
|
WO2011005496A2
(en)
|
2009-06-22 |
2011-01-13 |
Massachusetts Eye & Ear Infirmary |
Islet1 (isl1) and hearing loss
|
|
EP2451475A2
(de)
|
2009-07-06 |
2012-05-16 |
Novartis AG |
Selbstreplizierende rna-moleküle und ihre verwendung
|
|
EP4183412B1
(de)
|
2009-07-15 |
2024-08-14 |
GlaxoSmithKline Biologicals SA |
Rsv-f-proteinzusammensetzungen und verfahren zu ihrer herstellung
|
|
US20110112176A1
(en)
|
2009-11-09 |
2011-05-12 |
John Frederick Boylan |
Compositions and methods for inhibiting expression of kif10 genes
|
|
WO2011064751A1
(en)
|
2009-11-27 |
2011-06-03 |
Basf Plant Science Company Gmbh |
Chimeric endonucleases and uses thereof
|
|
CN102725412B
(zh)
|
2009-11-27 |
2017-09-22 |
巴斯夫植物科学有限公司 |
优化的内切核酸酶及其用途
|
|
AU2010325563B2
(en)
|
2009-11-27 |
2017-02-02 |
Basf Plant Science Company Gmbh |
Chimeric endonucleases and uses thereof
|
|
US20110152349A1
(en)
|
2009-12-18 |
2011-06-23 |
Anke Geick |
Compositions and methods for inhibiting expression of il-18 genes
|
|
WO2011088435A1
(en)
|
2010-01-15 |
2011-07-21 |
Cornell University |
Methods for reducing protein levels in a cell
|
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
|
US20110196016A1
(en)
|
2010-02-05 |
2011-08-11 |
Anke Geick |
Compositions and Methods for Inhibiting Expression of IKK2 Genes
|
|
US9115402B2
(en)
|
2010-05-14 |
2015-08-25 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods of identifying tumor specific neoantigens
|
|
EP2577309B1
(de)
|
2010-05-25 |
2016-11-23 |
Carnegie Mellon University |
Gezielte sonden für zellphysiologie
|
|
US20120101108A1
(en)
|
2010-08-06 |
2012-04-26 |
Cell Signaling Technology, Inc. |
Anaplastic Lymphoma Kinase In Kidney Cancer
|
|
KR102266691B1
(ko)
|
2010-10-11 |
2021-06-23 |
노파르티스 아게 |
항원 전달 플랫폼
|
|
EP3434772A3
(de)
|
2010-10-18 |
2019-03-20 |
Arrowhead Pharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur hemmung der expression von rrm2-genen
|
|
EP3026432A3
(de)
|
2010-12-27 |
2016-07-27 |
Brown University |
Verfahren zur vorhersage der patientenreaktion auf eine behandlung mit biglycan
|
|
ES3018416T3
(es)
|
2011-01-26 |
2025-05-16 |
Glaxosmithkline Biologicals Sa |
Régimen de inmunización del VRS
|
|
EP2508530A1
(de)
|
2011-03-28 |
2012-10-10 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Reinigung von triphosphorylierten Oligonucleotiden mit Einfang-Tags
|
|
RS56748B1
(sr)
|
2011-05-13 |
2018-03-30 |
Glaxosmithkline Biologicals Sa |
Pre-fuzioni rsv f antigeni
|
|
PT2726613T
(pt)
|
2011-06-30 |
2018-10-26 |
Arrowhead Pharmaceuticals Inc |
Composições e métodos para inibição da expressão de genes do vírus da hepatite b
|
|
BR112014006535A2
(pt)
|
2011-09-20 |
2017-03-28 |
Univ North Carolina Chapel Hill |
regulação dos canais de sódio através das proteínas plunc
|
|
BR112014008694A2
(pt)
|
2011-10-11 |
2017-06-20 |
Novartis Ag |
moléculas de ácido nucleico policistrônico recombinante
|
|
US20140348863A1
(en)
|
2011-10-12 |
2014-11-27 |
Alessia Bianchi |
Cmv antigens and uses thereof
|
|
WO2013082500A2
(en)
|
2011-12-02 |
2013-06-06 |
Rhode Island Hospital |
Vaccine for falciparum malaria
|
|
EP2612918A1
(de)
|
2012-01-06 |
2013-07-10 |
BASF Plant Science Company GmbH |
In planta-Rekombination
|
|
WO2013158859A1
(en)
|
2012-04-18 |
2013-10-24 |
Cell Signaling Technology, Inc. |
Egfr and ros1 in cancer
|
|
EP2877214B1
(de)
|
2012-07-26 |
2019-04-24 |
Joslin Diabetes Center, Inc. |
Prognose von mit diabetes assoziierten komplikationen
|
|
EP2712870A1
(de)
|
2012-09-27 |
2014-04-02 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Neuartige RIG-I-Liganden und Herstellungsverfahren dafür
|
|
EP2851086A1
(de)
|
2013-09-20 |
2015-03-25 |
Sanofi |
Serpine: Verfahren zur therapeutischen ß-Zellen-Regeneration und Funktion
|
|
EP2769732A1
(de)
|
2013-02-22 |
2014-08-27 |
Sanofi |
Serpine: Verfahren zur therapeutischen Beta-Zellen-Regeneration und Funktion
|
|
WO2014128257A1
(en)
|
2013-02-22 |
2014-08-28 |
Sanofi |
Serpins: methods of therapeutic beta-cell regeneration and function
|
|
ES2747833T3
(es)
|
2013-04-04 |
2020-03-11 |
Dartmouth College |
Composiciones y procedimientos para la escisión in vivo del ADN proviral del vih-1
|
|
AU2014251207B2
(en)
|
2013-04-07 |
2019-06-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for personalized neoplasia vaccines
|
|
WO2015050871A2
(en)
|
2013-10-04 |
2015-04-09 |
Novartis Ag |
Organic compounds to treat hepatitis b virus
|
|
EP3722277A3
(de)
|
2013-10-04 |
2021-01-20 |
Novartis AG |
3'-endkappen für rna-interferenz-wirkstoffe zur verwendung in rna
|
|
WO2015051366A2
(en)
|
2013-10-04 |
2015-04-09 |
Novartis Ag |
Novel formats for organic compounds for use in rna interference
|
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
|
JP7060324B2
(ja)
|
2013-12-20 |
2022-04-26 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
ネオ抗原ワクチンによる併用療法
|
|
WO2015150900A2
(en)
|
2014-03-31 |
2015-10-08 |
Debiopharm International Sa |
Fgfr fusions
|
|
CN107532162A
(zh)
|
2014-12-12 |
2018-01-02 |
托德·M·伍尔夫 |
用于利用寡核苷酸编辑细胞中核酸的组合物和方法
|
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
|
EP3234130B1
(de)
|
2014-12-19 |
2020-11-25 |
The Broad Institute, Inc. |
Verfahren zum profiling vom t-zell-rezeptor-repertoire
|
|
US20180043034A1
(en)
|
2015-03-06 |
2018-02-15 |
Massachusetts Eye And Ear Infirmary |
Gene augmentation therapies for inherited retinal degeneration caused by mutations in the prpf31 gene
|
|
US20180140626A1
(en)
|
2015-05-14 |
2018-05-24 |
Joslin Diabetes Center, Inc. |
Retinol-binding protein 3 (rbp3) as a protective factor in non-diabetic retinal degeneration
|
|
JP6913032B2
(ja)
|
2015-05-20 |
2021-08-04 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
共通ネオ抗原
|
|
TW202241500A
(zh)
|
2015-06-09 |
2022-11-01 |
美商博德研究所有限公司 |
用於贅瘤疫苗之調配物及其製備方法
|
|
CN115957337A
(zh)
|
2015-08-07 |
2023-04-14 |
箭头药业股份有限公司 |
乙型肝炎病毒感染的RNAi疗法
|
|
WO2017066796A2
(en)
|
2015-10-16 |
2017-04-20 |
The Children's Medical Center Corporation |
Modulators of telomere disease
|
|
WO2017066712A2
(en)
|
2015-10-16 |
2017-04-20 |
The Children's Medical Center Corporation |
Modulators of telomere disease
|
|
CA3005878A1
(en)
|
2015-11-19 |
2017-05-26 |
The Brigham And Women's Hospital, Inc. |
Lymphocyte antigen cd5-like (cd5l)-interleukin 12b (p40) heterodimers in immunity
|
|
JP7114477B2
(ja)
|
2015-12-16 |
2022-08-08 |
グリットストーン バイオ インコーポレイテッド |
新生抗原の特定、製造、および使用
|
|
US10619159B2
(en)
|
2016-01-19 |
2020-04-14 |
The University Of North Carolina At Chapel Hill |
Methods and compositions using RNA interference for inhibition of KRAS
|
|
JP2019512216A
(ja)
|
2016-02-22 |
2019-05-16 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
カルシウムチャネルのペプチド阻害剤
|
|
SG11201808196UA
(en)
|
2016-03-31 |
2018-10-30 |
Neon Therapeutics Inc |
Neoantigens and methods of their use
|
|
AU2017254477A1
(en)
|
2016-04-18 |
2018-11-01 |
Jennifer G. ABELIN |
Improved HLA epitope prediction
|
|
CA3022319A1
(en)
|
2016-05-06 |
2017-11-09 |
Tod M. Woolf |
Improved methods for genome editing with and without programmable nucleases
|
|
JOP20190015A1
(ar)
|
2016-08-04 |
2019-02-04 |
Arrowhead Pharmaceuticals Inc |
عوامل (ار ان ايه آي) لعدوى فيروس الالتهاب الكبدي الوبائي ب
|
|
EP3574116A1
(de)
|
2017-01-24 |
2019-12-04 |
The Broad Institute, Inc. |
Zusammensetzungen und verfahren zum nachweis einer mutanten variante eines polynukleotids
|
|
EP3606550A2
(de)
|
2017-04-03 |
2020-02-12 |
Neon Therapeutics, Inc. |
Proteinantigene und verwendungen davon
|
|
EP3609577B1
(de)
|
2017-04-14 |
2024-09-11 |
University of Massachusetts |
Braune fettselektive adipokine
|
|
KR102945203B1
(ko)
|
2017-05-08 |
2026-03-31 |
시애틀 프로젝트 코포레이션 |
알파바이러스 신생항원 벡터
|
|
WO2018213803A1
(en)
|
2017-05-19 |
2018-11-22 |
Neon Therapeutics, Inc. |
Immunogenic neoantigen identification
|
|
CA3066635A1
(en)
|
2017-06-09 |
2018-12-13 |
Gritstone Oncology, Inc. |
Neoantigen identification, manufacture, and use
|
|
CN111465989B
(zh)
|
2017-10-10 |
2024-06-25 |
磨石生物公司 |
使用热点进行的新抗原鉴别
|
|
AU2018373154B2
(en)
|
2017-11-22 |
2025-08-07 |
Seattle Project Corp. |
Reducing junction epitope presentation for neoantigens
|
|
KR20240134250A
(ko)
|
2018-01-04 |
2024-09-06 |
아이코닉 테라퓨틱스, 인코포레이티드 |
항-조직 인자 항체, 항체-약물 결합체, 및 관련 방법
|
|
EP3790893A4
(de)
|
2018-05-11 |
2022-03-16 |
University Of Massachusetts |
Verfahren zur verbesserung der leptinempfindlichkeit zur behandlung von fettleibigkeit und diabetes
|
|
US20210382068A1
(en)
|
2018-10-02 |
2021-12-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
|
KR20210090650A
(ko)
|
2018-11-07 |
2021-07-20 |
그릿스톤 바이오, 인코포레이티드 |
알파바이러스 신생항원 벡터 및 인터페론 억제제
|
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
|
SG11202113187WA
(en)
|
2019-05-30 |
2021-12-30 |
Gritstone Bio Inc |
Modified adenoviruses
|
|
JP2022536945A
(ja)
|
2019-06-18 |
2022-08-22 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
B型肝炎ウイルス(HBV)ワクチンおよびHBVを標的化するRNAiの組合せ
|
|
WO2020255008A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAi
|
|
JP7711045B2
(ja)
|
2019-09-02 |
2025-07-22 |
アンスティテュ・クリー |
腫瘍ネオアンチゲンペプチドを標的とする免疫療法
|
|
US12394502B2
(en)
|
2019-10-02 |
2025-08-19 |
The General Hospital Corporation |
Method for predicting HLA-binding peptides using protein structural features
|
|
US20220401539A1
(en)
|
2019-10-22 |
2022-12-22 |
Institut Curie |
Immunotherapy Targeting Tumor Neoantigenic Peptides
|
|
US12129496B2
(en)
|
2020-02-12 |
2024-10-29 |
Massachusetts Eye And Ear Infirmary |
Haplotype-based treatment of RP1 associated retinal degenerations
|
|
JP2023521662A
(ja)
|
2020-04-03 |
2023-05-25 |
グリットストーン バイオ インコーポレイテッド |
感染症抗原及びワクチン
|
|
EP4149952A1
(de)
|
2020-05-12 |
2023-03-22 |
Institut Curie |
Neoantigene epitope in zusammenhang mit sf3b1-mutationen
|
|
IL300026A
(en)
|
2020-08-06 |
2023-03-01 |
Gritstone Bio Inc |
Multiepitope vaccine cassettes
|
|
WO2022076812A2
(en)
|
2020-10-09 |
2022-04-14 |
University Of Massachusetts |
Targeting nrip1 to alleviate metabolic disease
|
|
US20220154223A1
(en)
|
2020-10-15 |
2022-05-19 |
Hoffmann-La Roche Inc. |
Nucleic acid constructs for simultaneous gene activation
|
|
WO2022079083A1
(en)
|
2020-10-15 |
2022-04-21 |
F. Hoffmann-La Roche Ag |
Nucleic acid constructs for va rna transcription
|
|
JP2024501482A
(ja)
|
2020-12-14 |
2024-01-12 |
ビオンテック ユーエス インコーポレイテッド |
がん免疫療法のための組織特異的抗原
|
|
WO2022155500A1
(en)
|
2021-01-14 |
2022-07-21 |
Senti Biosciences, Inc. |
Secretable payload regulation
|
|
CA3212964A1
(en)
|
2021-03-11 |
2022-09-15 |
Mnemo Therapeutics |
Tumor neoantigenic peptides
|
|
IL305804A
(en)
|
2021-03-11 |
2023-11-01 |
Inst Curie |
Transmembrane neoantigenic peptides
|
|
WO2022204185A1
(en)
|
2021-03-22 |
2022-09-29 |
The University Of North Carolina At Chapel Hill |
Modified peptidomimetics and methods of use
|
|
CN119816320A
(zh)
|
2022-03-24 |
2025-04-11 |
居里研究所 |
靶向胶质母细胞瘤中肿瘤转座元件衍生的新抗原肽的免疫疗法
|
|
EP4522754A1
(de)
|
2022-05-12 |
2025-03-19 |
Sunvax MRNA Therapeutics Inc. |
Synthetische selbstverstärkende mrna-moleküle mit sekretionsantigen und immunmodulator
|
|
WO2023230295A1
(en)
|
2022-05-25 |
2023-11-30 |
BioNTech SE |
Rna compositions for delivery of monkeypox antigens and related methods
|
|
CN114958912B
(zh)
*
|
2022-05-30 |
2023-11-10 |
新乡医学院 |
一种hek293细胞瞬时表达转染用试剂和瞬时表达系统转染方法
|
|
AU2024316307A1
(en)
|
2023-08-03 |
2026-02-26 |
BioNTech SE |
Pharmaceutical compositions for delivery of herpes simplex virus antigens and related methods
|
|
KR20260074976A
(ko)
|
2023-09-19 |
2026-05-27 |
리제너론 파마슈티칼스 인코포레이티드 |
바이러스 펩티드 및 이의 용도
|
|
WO2025088117A1
(en)
|
2023-10-25 |
2025-05-01 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Ribonucleic acid construct capable of inducing an immune response, as well as pharmaceutical composition and kit comprising same
|
|
CN122438694A
(zh)
|
2023-12-19 |
2026-07-21 |
瑞泽恩制药公司 |
Foxp3肽及其用途
|
|
WO2025158069A1
(en)
|
2024-01-25 |
2025-07-31 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
CONSTRUCT COMPRISING mRNA-STRAND AND RETINOIC ACID-INDUCIBLE GENE I (RIG-I)-LIGAND(S), PHARMACEUTICAL COMPOSITION AND KIT COMPRISING THE SAME
|
|
WO2025178991A1
(en)
|
2024-02-21 |
2025-08-28 |
Regeneron Pharmaceuticals, Inc. |
Splicing factor gene mutation-associated neoantigenic peptides and uses thereof
|
|
WO2025189168A1
(en)
|
2024-03-08 |
2025-09-12 |
SunVax mRNA Therapeutics Inc. |
Methods for cascade amplifications of therapeutic payloads (catp) & compositions for cancer immunotherapies and gene therapy
|
|
WO2026030428A2
(en)
|
2024-08-01 |
2026-02-05 |
Regeneron Pharmaceuticals, Inc. |
Prostate-specific antigen peptides and uses thereof
|
|
WO2026047025A1
(en)
|
2024-08-27 |
2026-03-05 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Photocontrollable conjugate, pharmaceutical composition and kit comprising the same, and uses thereof
|
|
EP4702988A1
(de)
|
2024-08-28 |
2026-03-04 |
Biotechnology Assets S.A. |
Kombinationsprodukt zur behandlung von leishmaniose
|
|
WO2026062222A1
(en)
|
2024-09-20 |
2026-03-26 |
Institut Curie |
Novel protein isoforms and uses
|
|
WO2026090560A1
(en)
|
2024-10-25 |
2026-04-30 |
Crank Bio, Inc. |
Engineered nucleic acids and uses thereof
|